Charah Solutions, Inc.
Charah Solutions, Inc. (CHRA) Stock Competitors & Peer Comparison
See (CHRA) competitors and their performances in Stock Market.
Peer Comparison Table: Waste Management Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CHRA | $5.96 | +0.17% | 20.3M | -0.15 | -$38.80 | N/A |
| WM | $229.67 | -0.41% | 92.4B | 34.57 | $6.64 | +1.37% |
| RSG | $245.16 | +0.02% | 76.6B | 37.02 | $6.62 | +0.95% |
| WCN | $186.95 | -0.69% | 48.3B | 75.40 | $2.48 | +0.66% |
| GFLU | $70.30 | +4.32% | 25B | -91.90 | -$0.77 | N/A |
| GFL | $48.22 | +0.40% | 17.1B | -31.31 | -$1.54 | +0.12% |
| CLH | $235.21 | +1.85% | 12.6B | 32.60 | $7.22 | N/A |
| CWST | $108.97 | +0.17% | 6.8B | 495.27 | $0.22 | N/A |
| SRCL | $61.98 | +0.83% | 5.8B | 158.92 | $0.39 | N/A |
| HCCI | $45.51 | +0.09% | 1.1B | 14.22 | $3.20 | N/A |
Stock Comparison
CHRA vs WM Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, WM has a market cap of 92.4B. Regarding current trading prices, CHRA is priced at $5.96, while WM trades at $229.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas WM's P/E ratio is 34.57. In terms of profitability, CHRA's ROE is +20.59%, compared to WM's ROE of +0.33%. Regarding short-term risk, CHRA is less volatile compared to WM. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check WM's competition here
CHRA vs RSG Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, RSG has a market cap of 76.6B. Regarding current trading prices, CHRA is priced at $5.96, while RSG trades at $245.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas RSG's P/E ratio is 37.02. In terms of profitability, CHRA's ROE is +20.59%, compared to RSG's ROE of +0.18%. Regarding short-term risk, CHRA is less volatile compared to RSG. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check RSG's competition here
CHRA vs WCN Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, WCN has a market cap of 48.3B. Regarding current trading prices, CHRA is priced at $5.96, while WCN trades at $186.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas WCN's P/E ratio is 75.40. In terms of profitability, CHRA's ROE is +20.59%, compared to WCN's ROE of +0.08%. Regarding short-term risk, CHRA is less volatile compared to WCN. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check WCN's competition here
CHRA vs GFLU Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, GFLU has a market cap of 25B. Regarding current trading prices, CHRA is priced at $5.96, while GFLU trades at $70.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas GFLU's P/E ratio is -91.90. In terms of profitability, CHRA's ROE is +20.59%, compared to GFLU's ROE of N/A. Regarding short-term risk, CHRA is less volatile compared to GFLU. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check GFLU's competition here
CHRA vs GFL Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, GFL has a market cap of 17.1B. Regarding current trading prices, CHRA is priced at $5.96, while GFL trades at $48.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas GFL's P/E ratio is -31.31. In terms of profitability, CHRA's ROE is +20.59%, compared to GFL's ROE of +0.40%. Regarding short-term risk, CHRA is less volatile compared to GFL. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check GFL's competition here
CHRA vs CLH Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, CLH has a market cap of 12.6B. Regarding current trading prices, CHRA is priced at $5.96, while CLH trades at $235.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas CLH's P/E ratio is 32.60. In terms of profitability, CHRA's ROE is +20.59%, compared to CLH's ROE of +0.15%. Regarding short-term risk, CHRA is less volatile compared to CLH. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check CLH's competition here
CHRA vs CWST Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, CWST has a market cap of 6.8B. Regarding current trading prices, CHRA is priced at $5.96, while CWST trades at $108.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas CWST's P/E ratio is 495.27. In terms of profitability, CHRA's ROE is +20.59%, compared to CWST's ROE of +0.01%. Regarding short-term risk, CHRA is less volatile compared to CWST. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check CWST's competition here
CHRA vs SRCL Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, SRCL has a market cap of 5.8B. Regarding current trading prices, CHRA is priced at $5.96, while SRCL trades at $61.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas SRCL's P/E ratio is 158.92. In terms of profitability, CHRA's ROE is +20.59%, compared to SRCL's ROE of +0.01%. Regarding short-term risk, CHRA is less volatile compared to SRCL. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check SRCL's competition here
CHRA vs HCCI Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, HCCI has a market cap of 1.1B. Regarding current trading prices, CHRA is priced at $5.96, while HCCI trades at $45.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas HCCI's P/E ratio is 14.22. In terms of profitability, CHRA's ROE is +20.59%, compared to HCCI's ROE of +0.22%. Regarding short-term risk, CHRA is less volatile compared to HCCI. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check HCCI's competition here
CHRA vs MEG Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, MEG has a market cap of 801.7M. Regarding current trading prices, CHRA is priced at $5.96, while MEG trades at $23.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas MEG's P/E ratio is -10.06. In terms of profitability, CHRA's ROE is +20.59%, compared to MEG's ROE of -0.15%. Regarding short-term risk, CHRA is less volatile compared to MEG. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check MEG's competition here
CHRA vs NVRI Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, NVRI has a market cap of 754.3M. Regarding current trading prices, CHRA is priced at $5.96, while NVRI trades at $9.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas NVRI's P/E ratio is -6.29. In terms of profitability, CHRA's ROE is +20.59%, compared to NVRI's ROE of -0.28%. Regarding short-term risk, CHRA is less volatile compared to NVRI. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check NVRI's competition here
CHRA vs HSC Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, HSC has a market cap of 729.6M. Regarding current trading prices, CHRA is priced at $5.96, while HSC trades at $9.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas HSC's P/E ratio is -5.08. In terms of profitability, CHRA's ROE is +20.59%, compared to HSC's ROE of -0.32%. Regarding short-term risk, CHRA is less volatile compared to HSC. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check HSC's competition here
CHRA vs AMBI Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, AMBI has a market cap of 257.7M. Regarding current trading prices, CHRA is priced at $5.96, while AMBI trades at $4.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas AMBI's P/E ratio is -66.43. In terms of profitability, CHRA's ROE is +20.59%, compared to AMBI's ROE of -0.00%. Regarding short-term risk, CHRA is less volatile compared to AMBI. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check AMBI's competition here
CHRA vs PESI Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, PESI has a market cap of 227.4M. Regarding current trading prices, CHRA is priced at $5.96, while PESI trades at $12.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas PESI's P/E ratio is -9.94. In terms of profitability, CHRA's ROE is +20.59%, compared to PESI's ROE of -0.37%. Regarding short-term risk, CHRA is less volatile compared to PESI. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check PESI's competition here
CHRA vs LNZA Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, LNZA has a market cap of 135.1M. Regarding current trading prices, CHRA is priced at $5.96, while LNZA trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas LNZA's P/E ratio is -0.87. In terms of profitability, CHRA's ROE is +20.59%, compared to LNZA's ROE of -2.96%. Regarding short-term risk, CHRA is less volatile compared to LNZA. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check LNZA's competition here
CHRA vs QRHC Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, QRHC has a market cap of 44.9M. Regarding current trading prices, CHRA is priced at $5.96, while QRHC trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas QRHC's P/E ratio is -1.81. In terms of profitability, CHRA's ROE is +20.59%, compared to QRHC's ROE of -0.44%. Regarding short-term risk, CHRA is less volatile compared to QRHC. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check QRHC's competition here
CHRA vs ENGS Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, ENGS has a market cap of 42.9M. Regarding current trading prices, CHRA is priced at $5.96, while ENGS trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas ENGS's P/E ratio is -43.00. In terms of profitability, CHRA's ROE is +20.59%, compared to ENGS's ROE of +0.28%. Regarding short-term risk, CHRA is less volatile compared to ENGS. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check ENGS's competition here
CHRA vs LICY Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, LICY has a market cap of 29.9M. Regarding current trading prices, CHRA is priced at $5.96, while LICY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas LICY's P/E ratio is -0.15. In terms of profitability, CHRA's ROE is +20.59%, compared to LICY's ROE of -0.34%. Regarding short-term risk, CHRA is less volatile compared to LICY. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check LICY's competition here
CHRA vs JAN Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, JAN has a market cap of 27.1M. Regarding current trading prices, CHRA is priced at $5.96, while JAN trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas JAN's P/E ratio is -0.51. In terms of profitability, CHRA's ROE is +20.59%, compared to JAN's ROE of +0.34%. Regarding short-term risk, CHRA is less volatile compared to JAN. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check JAN's competition here
CHRA vs DXST Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, DXST has a market cap of 18.8M. Regarding current trading prices, CHRA is priced at $5.96, while DXST trades at $1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas DXST's P/E ratio is 9.62. In terms of profitability, CHRA's ROE is +20.59%, compared to DXST's ROE of +0.54%. Regarding short-term risk, CHRA is less volatile compared to DXST. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check DXST's competition here
CHRA vs GWAV Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, GWAV has a market cap of 16.6M. Regarding current trading prices, CHRA is priced at $5.96, while GWAV trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas GWAV's P/E ratio is N/A. In terms of profitability, CHRA's ROE is +20.59%, compared to GWAV's ROE of -0.64%. Regarding short-term risk, CHRA is less volatile compared to GWAV. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check GWAV's competition here
CHRA vs CDTG Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, CDTG has a market cap of 11.3M. Regarding current trading prices, CHRA is priced at $5.96, while CDTG trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas CDTG's P/E ratio is 6.57. In terms of profitability, CHRA's ROE is +20.59%, compared to CDTG's ROE of +0.04%. Regarding short-term risk, CHRA is less volatile compared to CDTG. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check CDTG's competition here
CHRA vs AWX Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, AWX has a market cap of 10.3M. Regarding current trading prices, CHRA is priced at $5.96, while AWX trades at $2.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas AWX's P/E ratio is 12.62. In terms of profitability, CHRA's ROE is +20.59%, compared to AWX's ROE of +0.02%. Regarding short-term risk, CHRA is less volatile compared to AWX. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check AWX's competition here
CHRA vs AQMS Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, AQMS has a market cap of 5.2M. Regarding current trading prices, CHRA is priced at $5.96, while AQMS trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas AQMS's P/E ratio is -0.14. In terms of profitability, CHRA's ROE is +20.59%, compared to AQMS's ROE of -1.51%. Regarding short-term risk, CHRA is less volatile compared to AQMS. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check AQMS's competition here
CHRA vs CHNR Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, CHNR has a market cap of 4.6M. Regarding current trading prices, CHRA is priced at $5.96, while CHNR trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas CHNR's P/E ratio is -10.14. In terms of profitability, CHRA's ROE is +20.59%, compared to CHNR's ROE of -0.00%. Regarding short-term risk, CHRA is less volatile compared to CHNR. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check CHNR's competition here
CHRA vs SMED Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, SMED has a market cap of 0. Regarding current trading prices, CHRA is priced at $5.96, while SMED trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas SMED's P/E ratio is 36.46. In terms of profitability, CHRA's ROE is +20.59%, compared to SMED's ROE of +0.34%. Regarding short-term risk, CHRA is less volatile compared to SMED. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check SMED's competition here
CHRA vs ECOLW Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, ECOLW has a market cap of 0. Regarding current trading prices, CHRA is priced at $5.96, while ECOLW trades at $5.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas ECOLW's P/E ratio is N/A. In terms of profitability, CHRA's ROE is +20.59%, compared to ECOLW's ROE of +0.01%. Regarding short-term risk, CHRA and ECOLW have similar daily volatility (0.00).Check ECOLW's competition here
CHRA vs ECOL Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, ECOL has a market cap of 0. Regarding current trading prices, CHRA is priced at $5.96, while ECOL trades at $47.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas ECOL's P/E ratio is N/A. In terms of profitability, CHRA's ROE is +20.59%, compared to ECOL's ROE of +0.01%. Regarding short-term risk, CHRA is less volatile compared to ECOL. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check ECOL's competition here
CHRA vs CVA Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, CVA has a market cap of 0. Regarding current trading prices, CHRA is priced at $5.96, while CVA trades at $20.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas CVA's P/E ratio is N/A. In terms of profitability, CHRA's ROE is +20.59%, compared to CVA's ROE of -0.08%. Regarding short-term risk, CHRA is less volatile compared to CVA. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check CVA's competition here
CHRA vs NES Comparison July 2025
CHRA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHRA stands at 20.3M. In comparison, NES has a market cap of 0. Regarding current trading prices, CHRA is priced at $5.96, while NES trades at $2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHRA currently has a P/E ratio of -0.15, whereas NES's P/E ratio is -1.32. In terms of profitability, CHRA's ROE is +20.59%, compared to NES's ROE of -0.29%. Regarding short-term risk, CHRA is less volatile compared to NES. This indicates potentially lower risk in terms of short-term price fluctuations for CHRA.Check NES's competition here